ID   MYBA_HUMAN              Reviewed;         752 AA.
AC   P10243; E7EW29; Q495F9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   07-APR-2021, entry version 191.
DE   RecName: Full=Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310};
DE            Short=A-Myb {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310};
DE   AltName: Full=Myb-like protein 1;
GN   Name=MYBL1; Synonyms=AMYB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-745 (ISOFORM 1).
RX   PubMed=3060855; DOI=10.1093/nar/16.23.11075;
RA   Nomura N., Takahashi M., Matsui M., Ishii S., Date T., Sasamoto S.,
RA   Ishizaki R.;
RT   "Isolation of human cDNA clones of myb-related genes, A-myb and B-myb.";
RL   Nucleic Acids Res. 16:11075-11089(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 398-752 (ISOFORM 1), AND FUNCTION.
RX   PubMed=8058310;
RA   Golay J., Loffarelli L., Luppi M., Castellano M., Introna M.;
RT   "The human A-myb protein is a strong activator of transcription.";
RL   Oncogene 9:2469-2479(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 727-752 (ISOFORM 1/2), AND FUNCTION.
RX   PubMed=7987850;
RA   Ma X.P., Calabretta B.;
RT   "DNA binding and transactivation activity of A-myb, a C-myb-related gene.";
RL   Cancer Res. 54:6512-6516(1994).
RN   [7]
RP   IDENTIFICATION IN THE DREAM COMPLEX.
RX   PubMed=17531812; DOI=10.1016/j.molcel.2007.04.015;
RA   Litovchick L., Sadasivam S., Florens L., Zhu X., Swanson S.K.,
RA   Velmurugan S., Chen R., Washburn M.P., Liu X.S., DeCaprio J.A.;
RT   "Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex
RT   represses human cell cycle-dependent genes in quiescence.";
RL   Mol. Cell 26:539-551(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-394, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-602, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-199; LYS-592 AND LYS-602, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Transcription factor that specifically recognizes the
CC       sequence 5'-YAAC[GT]G-3' (PubMed:8058310, PubMed:7987850). Acts as a
CC       master regulator of male meiosis by promoting expression of piRNAs:
CC       activates expression of both piRNA precursor RNAs and expression of
CC       protein-coding genes involved in piRNA metabolism (By similarity). The
CC       piRNA metabolic process mediates the repression of transposable
CC       elements during meiosis by forming complexes composed of piRNAs and
CC       Piwi proteins and governs the methylation and subsequent repression of
CC       transposons, which is essential for the germline integrity (By
CC       similarity). Transcriptional activator of SOX30 (By similarity).
CC       {ECO:0000250|UniProtKB:P51960, ECO:0000269|PubMed:7987850,
CC       ECO:0000269|PubMed:8058310}.
CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at
CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,
CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The complex exists in quiescent
CC       cells where it represses cell cycle-dependent genes. It dissociates in
CC       S phase when LIN9, LIN37, LIN52 and LIN54 form a subcomplex that binds
CC       to MYBL2. {ECO:0000269|PubMed:17531812}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P51960}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10243-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10243-2; Sequence=VSP_042912;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of lymphoid and solid tumor
CC       lines cultured in vitro.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYBL1ID41468ch8q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC083928; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86912.1; -; Genomic_DNA.
DR   EMBL; BC101188; AAI01189.1; -; mRNA.
DR   EMBL; X13294; CAA31656.1; -; mRNA.
DR   EMBL; X66087; CAA46886.1; -; mRNA.
DR   CCDS; CCDS47867.1; -. [P10243-1]
DR   CCDS; CCDS55241.1; -. [P10243-2]
DR   PIR; S03423; S03423.
DR   RefSeq; NP_001073885.1; NM_001080416.3. [P10243-1]
DR   RefSeq; NP_001138227.1; NM_001144755.2. [P10243-2]
DR   SMR; P10243; -.
DR   BioGRID; 110688; 11.
DR   DIP; DIP-624N; -.
DR   IntAct; P10243; 7.
DR   STRING; 9606.ENSP00000429633; -.
DR   iPTMnet; P10243; -.
DR   PhosphoSitePlus; P10243; -.
DR   BioMuta; MYBL1; -.
DR   DMDM; 1171089; -.
DR   jPOST; P10243; -.
DR   MassIVE; P10243; -.
DR   MaxQB; P10243; -.
DR   PaxDb; P10243; -.
DR   PeptideAtlas; P10243; -.
DR   PRIDE; P10243; -.
DR   ProteomicsDB; 52584; -. [P10243-1]
DR   ProteomicsDB; 52585; -. [P10243-2]
DR   Antibodypedia; 1831; 213 antibodies.
DR   Ensembl; ENST00000522677; ENSP00000429633; ENSG00000185697. [P10243-1]
DR   Ensembl; ENST00000524176; ENSP00000428011; ENSG00000185697. [P10243-2]
DR   GeneID; 4603; -.
DR   KEGG; hsa:4603; -.
DR   UCSC; uc003xwj.4; human. [P10243-1]
DR   CTD; 4603; -.
DR   DisGeNET; 4603; -.
DR   GeneCards; MYBL1; -.
DR   HGNC; HGNC:7547; MYBL1.
DR   HPA; ENSG00000185697; Tissue enhanced (lymphoid).
DR   MIM; 159405; gene.
DR   neXtProt; NX_P10243; -.
DR   OpenTargets; ENSG00000185697; -.
DR   PharmGKB; PA31347; -.
DR   VEuPathDB; HostDB:ENSG00000185697.16; -.
DR   eggNOG; KOG0048; Eukaryota.
DR   GeneTree; ENSGT00940000157709; -.
DR   HOGENOM; CLU_015440_2_2_1; -.
DR   InParanoid; P10243; -.
DR   OMA; KSLQSNC; -.
DR   OrthoDB; 219341at2759; -.
DR   PhylomeDB; P10243; -.
DR   TreeFam; TF326257; -.
DR   PathwayCommons; P10243; -.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   SIGNOR; P10243; -.
DR   BioGRID-ORCS; 4603; 24 hits in 1014 CRISPR screens.
DR   ChiTaRS; MYBL1; human.
DR   GenomeRNAi; 4603; -.
DR   Pharos; P10243; Tbio.
DR   PRO; PR:P10243; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P10243; protein.
DR   Bgee; ENSG00000185697; Expressed in calcaneal tendon and 236 other tissues.
DR   ExpressionAtlas; P10243; baseline and differential.
DR   Genevisible; P10243; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007141; P:male meiosis I; ISS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010529; P:negative regulation of transposition; ISS:UniProtKB.
DR   GO; GO:1990511; P:piRNA biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   InterPro; IPR015395; C-myb_C.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017930; Myb_dom.
DR   InterPro; IPR028317; MYBL1.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR012642; Tscrpt_reg_Wos2-domain.
DR   PANTHER; PTHR45614:SF9; PTHR45614:SF9; 1.
DR   Pfam; PF09316; Cmyb_C; 1.
DR   Pfam; PF07988; LMSTEN; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   SMART; SM00717; SANT; 3.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS51294; HTH_MYB; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Differentiation; DNA-binding;
KW   Isopeptide bond; Nucleus; Reference proteome; Repeat; Spermatogenesis;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..752
FT                   /note="Myb-related protein A"
FT                   /id="PRO_0000197054"
FT   DOMAIN          30..81
FT                   /note="HTH myb-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DOMAIN          82..137
FT                   /note="HTH myb-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DOMAIN          138..188
FT                   /note="HTH myb-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DNA_BIND        58..81
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DNA_BIND        110..133
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DNA_BIND        161..184
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   REGION          230..295
FT                   /note="Transcriptional activation domain"
FT                   /evidence="ECO:0000250"
FT   REGION          298..553
FT                   /note="Negative regulatory domain"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         394
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   CROSSLNK        199
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        592
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        602
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         650..709
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042912"
SQ   SEQUENCE   752 AA;  85887 MW;  4C6D1823A7CAFCDA CRC64;
     MAKRSRSEDE DDDLQYADHD YEVPQQKGLK KLWNRVKWTR DEDDKLKKLV EQHGTDDWTL
     IASHLQNRSD FQCQHRWQKV LNPELIKGPW TKEEDQRVIE LVQKYGPKRW SLIAKHLKGR
     IGKQCRERWH NHLNPEVKKS SWTEEEDRII YEAHKRLGNR WAEIAKLLPG RTDNSIKNHW
     NSTMRRKVEQ EGYLQDGIKS ERSSSKLQHK PCAAMDHMQT QNQFYIPVQI PGYQYVSPEG
     NCIEHVQPTS AFIQQPFIDE DPDKEKKIKE LEMLLMSAEN EVRRKRIPSQ PGSFSSWSGS
     FLMDDNMSNT LNSLDEHTSE FYSMDENQPV SAQQNSPTKF LAVEANAVLS SLQTIPEFAE
     TLELIESDPV AWSDVTSFDI SDAAASPIKS TPVKLMRIQH NEGAMECQFN VSLVLEGKKN
     TCNGGNSEAV PLTSPNIAKF STPPAILRKK RKMRVGHSPG SELRDGSLND GGNMALKHTP
     LKTLPFSPSQ FFNTCPGNEQ LNIENPSFTS TPICGQKALI TTPLHKETTP KDQKENVGFR
     TPTIRRSILG TTPRTPTPFK NALAAQEKKY GPLKIVSQPL AFLEEDIREV LKEETGTDLF
     LKEEDEPAYK SCKQENTASG KKVRKSLVLD NWEKEESGTQ LLTEDISDMQ SENRFTTSLL
     MIPLLEIHDN RCNLIPEKQD INSTNKTYTL TKKKPNPNTS KVVKLEKNLQ SNCEWETVVY
     GKTEDQLIMT EQARRYLSTY TATSSTSRAL IL
//
